Kaya Holdings (KAYS) Net Margin (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Net Margin of 158865.85% in Q3 2025, down 540.24% quarter-over-quarter from 24813.29% in Q2 2025, and down 7568828.0% on a YoY basis from N/an in Q3 2024.
Kaya Holdings (KAYS) Net Margin (2014 - 2025) Analysis & Trends
Kaya Holdings' Net Margin history runs 12 years deep, the most recent figure standing at 158865.85% for Q3 2025.
- In Q3 2025, Net Margin fell 7568828.0% year-over-year to 158865.85%; the TTM figure through Sep 2025 stood at 1053953.26% (up 105885649.0% YoY), while the FY2024 annual figure was 31154.36%, down 3198805.0% from the prior year.
- Net Margin was 158865.85% for Q3 2025 at Kaya Holdings, down from 24813.29% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 4678.0% in Q4 2024 to a low of 158865.85% in Q3 2025.
- Historically, Net Margin has averaged 16235.31% across 5 years, with a median of 221.36% in 2023.
- The sharpest annual moves came in 2023 and 2024: Net Margin surged 714798 bps in 2023, then tumbled 8436787 bps in 2024.
- A 5-year view of Net Margin shows it stood at 6576.4% in 2021, then decreased by 6 bps to 6970.87% in 2022, then surged by 103 bps to 177.11% in 2023, then surged by 2541 bps to 4678.0% in 2024, then tumbled by 3496 bps to 158865.85% in 2025.
- The last three Net Margin figures came in at 158865.85% (Q3 2025), 24813.29% (Q2 2025), and 23785.72% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -158,865.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -158,865.85% |
| Jun 30, 2025 | -24,813.29% |
| Mar 31, 2025 | -23,785.72% |
| Dec 31, 2024 | 4,678.00% |
| Sep 30, 2024 | -83,177.57% |
| Mar 31, 2024 | -3,947.59% |
| Dec 31, 2023 | 177.11% |
| Sep 30, 2023 | 1,190.30% |
| Jun 30, 2023 | 1,085.80% |
| Mar 31, 2023 | 139.20% |
| Dec 31, 2022 | -6,970.87% |
| Sep 30, 2022 | 4,286.86% |
| Jun 30, 2022 | 1,572.73% |
| Mar 31, 2022 | -581.93% |
| Dec 31, 2021 | -6,576.40% |
| Sep 30, 2021 | 1,846.19% |
| Jun 30, 2021 | 3,836.49% |
| Mar 31, 2021 | -2,329.02% |
| Dec 31, 2020 | 1,325.05% |
| Sep 30, 2020 | -4,873.04% |